1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow PE regimen: new trials by email Literature Review of PE regimen trials Research Report on PE regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer Surufatinib,Etoposide,Cisplatin,Toripalimab, Surufatinib,Etoposide,Cisplatin - Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 88 | 2021-11-09 | 2022-11-14 |
| A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer ABT-263, etoposide/cisplatin - Solid Tumors | Phase 1 | Completed | AbbVie (prior sponsor, Abbott) | 12 | 2009-10-01 | 2018-06-06 |
AbbVie (prior sponsor, Abbott) (1) · Sun Yat-sen University (1)
China (1) · United States (1)
Mack Mabry, MD (1)